Archives: Market Insights
-
IKON Market Brief: US News' 2025-26 Best Hospitals lists home in on outcomes
Among nearly 4,500 evaluated hospitals, the highly watched annual accolades awarded 16% some form of “Best Hospitals” designation.Source: www.fiercehealthcare.comIKON Portfolio ContextOur healthcare vertical includes Renew Republic Health (precision medicine, TRT, peptide therapy) and Renew Lab Group (pharmaceutical testing), both headquartered… Read more
-
Texas Energy Corridor: Midstream Capacity Expansion Accelerates in Q3 2026
Ikon Midstream 400,000 bbl storage expansion positions IKON Group for sustained fuel distribution growth across Gulf Coast markets. Read more
-
IKON Market Brief: US News' 2025-26 Best Hospitals lists home in on outcomes
Among nearly 4,500 evaluated hospitals, the highly watched annual accolades awarded 16% some form of “Best Hospitals” designation.Source: www.fiercehealthcare.comIKON Portfolio ContextOur healthcare vertical includes Renew Republic Health (precision medicine, TRT, peptide therapy) and Renew Lab Group (pharmaceutical testing), both headquartered… Read more
-
Private Aviation Charter Demand Rebounds as Corporate Travel Returns
BDP Airways reports increased charter inquiries from energy executives and healthcare leaders in the Houston metropolitan area. Read more
-
IKON Market Brief: Why payers should have these 3 pipeline drugs on their radar
Optum Rx’s latest look at the drug development pipeline highlights three drugs for rare and chronic conditions that payers and plan sponsors should be watching.Source: www.fiercehealthcare.comIKON Portfolio ContextIKON Group Investments manages 11 portfolio companies across energy, healthcare, aviation, real estate,… Read more
-
Children Mental Health: Faith-Based Models Show Measurable Community Impact
Ikon Kids expands to 90+ US cities, partnering with Santa Maria Hostel to serve 5,400+ women and children annually in Houston. Read more
-
IKON Market Brief: Why payers should have these 3 pipeline drugs on their radar
Optum Rx’s latest look at the drug development pipeline highlights three drugs for rare and chronic conditions that payers and plan sponsors should be watching.Source: www.fiercehealthcare.comIKON Portfolio ContextIKON Group Investments manages 11 portfolio companies across energy, healthcare, aviation, real estate,… Read more
-
Research Peptide Market Projected to Reach $12B Globally by 2028
Kynetide Peptides leads IKON life sciences growth with 99%+ HPLC-verified compounds serving 2,400+ research institutions. Read more
-
IKON Market Brief: CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
The Inpatient Prospective Payment System (IPPS) final rule’s base pay increase is slightly below what was proposed earlier this year, though the agency said it now expects the rule’s changes to bring hospital payments hundreds of millions of dollars higher… Read more
-
Global Luxury Real Estate: Sustainable Mixed-Use Development Trends for 2026
BDP Development international portfolio across Houston, Dubai, and London reflects accelerating demand for eco-community and mixed-use projects. Read more